Mercator Medical S.A. (MRC) - Total Assets
Based on the latest financial reports, Mercator Medical S.A. (MRC) holds total assets worth zł1.00 Billion PLN (≈ $276.27 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See MRC net asset value for net asset value and shareholders' equity analysis.
Mercator Medical S.A. - Total Assets Trend (2012–2024)
This chart illustrates how Mercator Medical S.A.'s total assets have evolved over time, based on quarterly financial data.
Mercator Medical S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Mercator Medical S.A.'s total assets of zł1.00 Billion consist of 60.8% current assets and 39.2% non-current assets.
| Asset Category | Amount (PLN) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | zł0.00 | 11.8% |
| Accounts Receivable | zł91.86 Million | 8.8% |
| Inventory | zł214.65 Million | 20.6% |
| Property, Plant & Equipment | zł0.00 | 0.0% |
| Intangible Assets | zł31.75 Million | 3.0% |
| Goodwill | zł0.00 | 0.0% |
Asset Composition Trend (2012–2024)
This chart illustrates how Mercator Medical S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Mercator Medical S.A. market cap and net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Mercator Medical S.A.'s current assets represent 60.8% of total assets in 2024, an increase from 56.4% in 2012.
- Cash Position: Cash and equivalents constituted 11.8% of total assets in 2024, up from 4.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 3.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is inventory at 20.6% of total assets.
Mercator Medical S.A. Competitors by Total Assets
Key competitors of Mercator Medical S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
iRay Technology Co Ltd
SHG:688301
|
China | CN¥11.33 Billion |
|
Nanosonics Ltd
AU:NAN
|
Australia | AU$272.48 Million |
|
Jiangsu Nanfang Medical
SHG:603880
|
China | CN¥993.46 Million |
|
MEDIMI AB AK
F:79T
|
Germany | €1.70 Million |
|
Ansell Ltd
AU:ANN
|
Australia | AU$3.32 Billion |
|
SDI Ltd
AU:SDI
|
Australia | AU$141.20 Million |
|
Austco Healthcare Ltd
AU:AHC
|
Australia | AU$91.07 Million |
|
Trajan Group Holdings Ltd
AU:TRJ
|
Australia | AU$192.32 Million |
Mercator Medical S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 6.95 | 6.28 | 4.57 |
| Quick Ratio | 4.54 | 4.76 | 3.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | zł474.87 Million | zł499.80 Million | zł855.63 Million |
Mercator Medical S.A. - Advanced Valuation Insights
This section examines the relationship between Mercator Medical S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.42 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 8.1% |
| Total Assets | zł1.04 Billion |
| Market Capitalization | $122.06 Million USD |
Valuation Analysis
Below Book Valuation: The market values Mercator Medical S.A.'s assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Mercator Medical S.A.'s assets grew by 8.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Mercator Medical S.A. (2012–2024)
The table below shows the annual total assets of Mercator Medical S.A. from 2012 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | zł1.04 Billion ≈ $287.17 Million |
+8.10% |
| 2023-12-31 | zł965.23 Million ≈ $265.64 Million |
-10.88% |
| 2022-12-31 | zł1.08 Billion ≈ $298.08 Million |
-15.95% |
| 2021-12-31 | zł1.29 Billion ≈ $354.62 Million |
-0.06% |
| 2020-12-31 | zł1.29 Billion ≈ $354.84 Million |
+233.40% |
| 2019-12-31 | zł386.71 Million ≈ $106.43 Million |
+1.10% |
| 2018-12-31 | zł382.51 Million ≈ $105.27 Million |
+32.48% |
| 2017-12-31 | zł288.74 Million ≈ $79.47 Million |
+38.92% |
| 2016-12-31 | zł207.85 Million ≈ $57.20 Million |
+31.56% |
| 2015-12-31 | zł157.99 Million ≈ $43.48 Million |
+11.30% |
| 2014-12-31 | zł141.95 Million ≈ $39.07 Million |
+41.60% |
| 2013-12-31 | zł100.25 Million ≈ $27.59 Million |
+32.33% |
| 2012-12-31 | zł75.76 Million ≈ $20.85 Million |
-- |
About Mercator Medical S.A.
Mercator Medical S.A., together with its subsidiaries, manufactures and distributes disposable medical gloves, dressings, and non-woven fabric products in Poland, the Czech Republic, Ukraine, France, Hungary, Italy, Romania, Germany, rest of Europe, and Thailand. The company offers surgical and protective, sterile examination and protective, and household gloves; glove brackets; and household and… Read more